Life Sciences
CASE STUDY: Creating a Future-Ready Model for Global MedTech Leader
Discover how a global MedTech leader deployed OPAL Enable to…
From Pressure to Possibility: Key Insights from our MedTech Roundtable
Anja Schaefer, Welocalize Global Head of Commercial for Life Sciences,…
The Silent Bottleneck in Clinical Trials
How translation delays jeopardize First-Patient-In, regulatory submissions, and trial start-up…
AI in Pharmacovigilance: Simplifying ICSR Content Management
Discover how AI is transforming ICSR content management, streamlining workflows,…
EMA’s Guiding Principles on LLMs: Reshaping Regulatory Translation
Discover how the EMA’s Guiding Principles on LLMs are transforming…
CASE STUDY: Multilingual Training Made Simple for Life Sciences Leader
Delivering a 50-minute training video subtitled in 13 languages as…
How FDA and EMA Shape Linguistic Validation in Clinical Research
As clinical research becomes global, understanding how to meet regulatory…
Regulatory Compliance in Pharmacovigilance Translations: EMA, FDA, and MHRA Requirements Explained
As the range of medicinal products grows, regulatory bodies such…
From ICSRs to AI: Compliant Strategies for Pharmacovigilance Translation
Our presentation at the 8th Annual Pharmacovigilance Summit
Navigating the Complexities of Linguistic Validation for Multinational Clinical Trials
Linguistic validation ensures accurate, culturally appropriate data in multinational clinical…
Dan O’Brien
Erin Wynn
Chris Grebisz
Christy Conrad
Matt Grebisz
Siobhan Hanna
Kimberly Olson
Nicole Sheehan